Thursday, 16 January 2020

Healthcare Revenue Cycle Management Market 2019 Business Trends, Regional Study, Size, Share, Industry Profit Growth and Global Segments by Forecast to 2027


Healthcare Revenue Cycle Management Market Research Report, by Product Type (Integrated, Standalone Software) Component (Software, Services) Deployment (On Premise, Cloud Based) End-user (Hospital, Ambulatory Service)- Global Forecast Till 2027

Market Scenario
The report covers the latest trends impacting the market to provide the most accurate forecasts and predictions. By correlating the historical data with upcoming market dynamics, our analysts can make highly astute projections. MRFR’s report includes a thorough analysis of the global healthcare revenue cycle management market segmented according to type, application, end-user, and region. Growth opportunities are highlighted coupled with the market share of companies as well as their valuation in the market. It analyzes new revenue sources for players and outlines the various strategies implemented by players.
The global healthcare revenue cycle management market is touted to exhibit a healthy 12.2% CAGR during the assessment period (2017-2027), as per a new market report by Market Research Future (MRFR).
The rising costs of surgeries and overall healthcare has induced the need for hospitals to lean towards technology to reduce the burden. Healthcare revenue cycle management (RCM) is a system in the healthcare cycle which relies on electronic health records (EHRs) and automation to expedite outpatient billing and reduce wait times. The growing numbers of hospitals and clinics, rising adoption rate of RCM software, recovery audits, and preference for integrated healthcare systems are factors expected to drive market demand during the forecast period.
Regional Analysis:
The geographical analysis of the market covers namely the Americas, Europe, Asia Pacific (APAC) and the Middle East & Africa (MEA).
The Americas take the onus of generating the maximum revenue as the region has this tendency to rely heavily on advanced technology. Advanced infrastructure accommodates such a wide-spread implementation of RCM software which benefits all. In addition, the market is profiting much from several major players presence in the segment, along with a scheduled substantial healthcare expenditure every year.
Europe is holding the second position, and it can be attributed to increasing government support in research and development. Other features such as well-developed healthcare infrastructure and considerable healthcare funding are quite similar in their impact to that of the Americas.
The APAC is all set to register the fastest Healthcare Revenue Cycle Management market growth. Emerging economies of the region are changing the healthcare sector remarkable, and many of them are evolving as a medical tourism hub which as a consequence, is assertively impacting the global RCM market. However, the MEA is still lagging much behind as the region has quite a few poor and slow developing countries.
Segmentation:
Based on the product type, the market can be segmented into advanced integrated software and standalone software. The advanced integrated software accrues almost 81.4% of the total revenue generated in the market and is blessed with the fastest CAGR of 12.3% during the forecast period.   
Component-based segmentation of the market includes software and services. The software segment is gaining precedence considerably in the global market owing to its applicational ease, and it commanded the largest market share in 2016.
Deployment-wise segmentation comprises on-premise and on-cloud/web-based. On-cloud section is gaining much traction. However, on-premise application held the largest share of the market in 2016 as many still find complete cloud solution a bit difficult to operate.
Based on end-users, the market can be segmented into hospitals and ambulatory services. Hospitals hold the major share, and many rely heavily on its assistance in cases of emergency. 
Browse More Healthcare IT Reports @
https://www.marketresearchfuture.com/categories/healthcare-it-market-report

Posted by at No comments:

Americas Blood Glucose Test Strip Packaging Market 2019 Business Trends, Regional Study, Size, Share, Industry Profit Growth and Global Segments by Forecast to 2021

Americas Blood Glucose Test Strip Packaging Market Information, by product (diagnostic, therapeutics, medical care and nutrition and wellness) by application (diagnosis and intervention, drug development and usage, cancer genomics and others), by End users (hospitals, molecular diagnostic laboratories and testing centers, academic institutes, bio and health informatics companies and others)- Forecast to 2023 
Market Synopsis of Americas Blood Glucose Test Strip Packaging Market:
An expert on premium research reports, Market Research Future has added a report titled "Americas Blood Glucose Test Strip Packaging Market Research Report – Forecast to 2021" to its offering. The report provides an in-depth analysis of regional data and an accurate projection of the market size and share of the Top 10 market players across the globe.
Americas Blood Glucose Test Strip Packaging Market– Forecast to 2021 The report firstly introduced Americas Blood Glucose Test Strip Packaging Market including classification, application and industry chain overview; Then we deeply analyzed Americas growth forecast indicators by the as well as the regional market conditions that including the product price, profit, utilization, supply, demand and industry growth rate etc.
In the end, the report introduced medical suction device market SWOT analysis, PEST analysis, market share analysis and competitive landscape, company profiles by analyzing the major players. It is a depth research study on Americas Blood Glucose Test Strip Packaging Market trends. We are thankful for the support and assistance from Americas Blood Glucose Test Strip Packaging Market chain related technical experts and marketing experts during Research Team survey and interviews.
Posted by at No comments:

Enema Based Products Industry Overview, Trends and Market Growth Analysis Research Report 2023

The global enema based products market is expected to show sharp growth over the forecast period. Rising prevalence of gastrointestinal disorders such as constipation across the globe, availability of various types of enema administration kits such as cleansing and carminative enema and overall demand for enema administration products drivers the market growth.
Enema based products are used to remove waste for the rectum and can be used at home as a remedial measure for constipation and other gastrointestinal disorders. Constipation is a major gastrointestinal condition, found to be prevalent across the globe. Other condition that may require enema administration are obesity, diabetes, and cancer.
Risk involved in the use of enema based product is irritation in the rectum and embolism, in case of incorrect use of enema administration
According to the latest 2016 data from the World Health Organization, an estimated 422 million adults were living with diabetes mellitus across the globe.
The global enema based products market is expected to grow at a CAGR of 10.2% during the forecast period.
Regional Analysis
The global enema based products market size by regional basis is segmented into regions namely Americas, Europe, Asia Pacific and the Middle East & Africa. America is the largest market for enema based products owing to increasing use of enema based products at home, and rising demand for enema kits by healthcare providers. According to the Canadian Journal of Gastroenterology, constipation is a common problem among the people in the North American region. One of the study stated that the 20% of the North American population suffer from constipation.
Europe is the second largest market owing rise in the number of enema administration procedures in the hospitals. Rising prevalence of constipation, diarrhea, and obesity also contributes to the progress of the market. Prevalence of diabetes is also found to be increasing in the Europe. According to the World Health Organization, nearly 60 million people with diabetes in the European Region and the prevalence is higher among people aging 25 years and above.
In Asia Pacific, the prevalence of chronic diseases such as diabetes and obesity is found to be increasing. Diabetes is one of the major problem in China and India. India has world’s second largest population of diabetic patients, around 69.2 million in 2015 and that are expected to increase to 123.5 million by 2040. The number of undiagnosed diabetes is higher in India which was around 36 million in 2015.
The Middle East & Africa also shows a steady rise in the market owing to lack of physical exercise, increasing problem of constipation and availability of enema based products in the market.
Key Players
Some of the key players in this market are Baxter International, Inc. (U.S), MacoPharma (U.K),  Hollister Incorporated  (U.S), Coloplast Group (Germany), Medline Industries, Inc. (U.S), and B Braun Melsungen AG (Germany).
Segments 
The global enema based products market is segmented on the basis of administration type, indication, preparation, and end users.
On the basis of administration type, market is segmented into cleansing enema, carminative enema, retention enema, return-flow enema, and others. Cleansing enema is further segmented into large volume enema, small volume enema, and prepackaged disposable enema. Retention enema is further segmented into oil enema, sedative enema, nutrient enema, anesthetic enema, medicinal enema, and others.
On the basis of indication, the market is market is segmented into constipation, diarrhea, obesity, cancer and others.
On the basis of preparation, the market is divided into sodium phosphate enemas, coffee enemas, barium enemas, water-soluble contrast enemas and others.  Barium enemas is further segmented into single-column barium enema and double-contrast barium enema.
On the basis of end user, the market is divided into hospitals or clinics, home, and others. 
Posted by at No comments:

Cardiac Valve Industry Overview, Trends and Market Growth Analysis Research Report 2023

Global Cardiac Valve Market Research Report: Information by Treatment (Cardiac Valve Repair and Cardiac Valve Replacement), Type (Mechanical Valves, Tissue/Bioprosthetic Valves, Transcatheter Heart Valves/ Percutaneous Heart Valves and others), Position (Mitral Valve Aortic Valve and other Position), End-User (Hospital & Clinics, Specialty Centers, Cardiac Research Institute and others) and Region (Americas, Europe, Asia-Pacific and Middle East & Africa) - Forecast till 2025
Market scenario
An expert on premium research reports, Market Research Future asserts that, Global Cardiac Valve Market is expected to grow at a CAGR of 11.5% during the forecasted period.
Cardiac valve or heart valve allows blood to flow in only one direction through the heart. Human heart consists of four valves. These valves open and closes compulsory on differential blood pressure on each side.
Furthermore, valve replacement remains the most widely used technique but the proportion of valve repair procedures is increasing in experienced treatment centres. Moreover, increasing development in medical technology and its wide range of application used in the treatment of various cardiac diseases will fuel the growth of the market. However, high cost of the treatment likely to restrain the growth of the market over the assessment period. The global cardiac valve market growth is expected to grow at a CAGR of 11.5% during the forecast period.
Key players
Medtronic (U.S.), Edwards Lifesciences Corporation (U.S.), Boston Scientific Corporation (U.S.), St. Jude Medical, Inc. (an Abbott Laboratories Company) (U.S.), LivaNova PLC (U.K), Symetis SA (Switzerland), Jenavalve Technology, Inc. (Germany), CryoLife, Inc. (U.S.), TTK HealthCare (India), Colibri Heart Valve, LLC (U.S.), Lepu Medical Technology Co., Ltd. (China), and Braile Biomédica (Brazil) are some of the prominent players at the forefront of competition in the Global Cardiac Valve Market and are profiled in MRFR Analysis. 
Segmentation
The global cardiac valve market is segmented on the basis of types, by diseases, by treatment, and by end users.
On the basis of treatments, it is segmented into valve replacement, valve repair, and others.
On the basis of types, the market is segmented into trans-catheter heart valve, tissue heart valve, mechanical heart valve, and others.
On the basis of disease, the market is segmented into aortic valve replacement, heart valve disease, mitral valve stenosis, and others.
On the basis of end users the market is segmented into cardiac research institute, hospital & clinics, and others.
Regional analysis
The Americas mainly include North America and South America of which North America dominates the market owing to the presence of huge number of patient with cardiac diseases, increasing geriatric population, and increasing healthcare expenditure.  
In Asia Pacific, increasing government support for research & development in healthcare domain, growing number of cardiovascular diseases drive the growth of the market in this region.
Europe is the second highest revenue generating region in the cardiac valve market. Europe is mainly consist of Eastern Europe and Western Europe. More developed countries of Western Europe such as Germany, France, and the UK are holding the major market share, whereas the East European countries are also growing at a significant rate. Moreover, owing to developing healthcare infrastructure and increasing healthcare expenditure will boost the market growth in this region.
The Middle East & Africa is expected to show a least market share due to less availability of medical facilities, and less development in healthcare domain
Posted by at No comments:

Surgical Equipment Market Growth Trends, Size Estimation, Industry Analysis, Sales Statistics, Global Share, Leading Key Players and Regional Forecast 2023

Surgical Equipment Market Analysis Published by Market Research Future predicts that The Global Surgical Equipment Market is expected to grow at a CAGR of 6.2% during the forecast period. Surgical Equipment Industry by Product Type (Surgical Sutures & Staplers, Handheld Instruments, Electrosurgical Devices), by Application (Neurosurgery, Wound Closure), by End-User (Hospitals, Ambulatory Surgical Centers) and Global Forecast Till 2023
Surgical equipment are used for both minor and major surgical procedures in hospitals and surgical centers and have a wide range of application in neurosurgery, ophthalmic surgery, wound closure, urology, cardiovascular surgeries, orthopedic surgery, and others. Electrosurgical devices, surgical sutures and staples, handheld instruments, electrosurgical generators, and monitoring devices are the various equipment that are used in surgeries.
The global surgical equipment market is expected to grow at a CAGR of 6.2% during the forecast period.
The global surgical equipment market is driven by the increasing prevalence of chronic diseases such as cardiovascular diseases, obesity, skin diseases, increasing number of surgeries in ambulatory surgical centers and hospitals, and rising geriatric population. Additionally, the growth of the medical device market, increasing number of surgical centers, and government initiatives have a synergistic effect on the market. However, the growth of the market is restrained by various factors such as high cost of surgical devices and strict regulatory policies for various regulatory authorities.
Segmentation
The global surgical equipment market is divided into product type, application, and end-user.
On the basis of product type, the market is segmented into surgical sutures and staplers, handheld instruments, electrosurgical devices, electrosurgical generators, monitoring devices, and others. Surgical sutures and staplers are further segmented into absorbable and non-absorbable sutures. Handheld instruments are sub-segmented into forceps, sutures, visual scope, and others. Electrosurgical devices are further categorized into electrosurgical instruments such as HET bipolar system, electrosurgical pencils, smoke evacuation system, electrosurgical generators, and others.
On the basis of application, the market is segmented into neurosurgery, wound closure, urology, cardiovascular surgeries, orthopedic surgery, and others.
On the basis of end-user, the market is segmented into hospitals, ambulatory surgical centers, and others.
Regional Analysis
Depending on geographic region, surgical equipment market is segmented into four key regions: Americas, Europe, Asia Pacific, and Middle East & Africa. Americas is the largest market for surgical equipment owing to increasing prevalence of different diseases and increasing geriatric population. Moreover, technological innovation in manufacturing of surgical equipment also is also responsible for the growth of this market in the U.S. Large number of patients undergo different kind of surgeries contribute to an increase in the demand of surgical equipment in Americas. Laparoscopic surgeries are done on a large scale in South America favouring the growth of this market. Canada are focusing on exporting surgical equipment’s and surgical suturing material to countries worldwide, which is increasing market in this region. Furthermore, increasing number of hospitals and healthcare services, availability of raw material and better access to labour will fuel the growth of this market.
Europe holds the second largest surgical equipment market share due to increasing prevalence of different types of diseases especially cardiovascular disease are increasing continuously in the developed as well as developing countries due to diabetes, hyper tension and lifestyle habits like smoking, sedentary work and lack of exercise has increased the prevalence of disease. Moreover, increase in chronic diseases has led to increase in the number of surgeries and healthcare organization.
European countries like U.K, Germany and France spend a lot on the manufacturing of medical and surgical devices. Asia pacific is fastest growing region during forecast period.
China dominates the Asia Pacific surgical equipment market owing to the presence of huge geriatric population. India accounts for the second largest market, which is followed by Japan and Australia. Huge population base, rapidly changing economy, increasing prevalence of chronic diseases, increasing healthcare expenditure, and increasing number of companies have encouraged the market growth in India and China. Recent economic data suggests that China and Southeast Asia are poised to join the ranks of the high-growth Asian economies such as Korea and Taiwan. On the other hand, the Middle East & Africa have the least market share. Additionally, factors such as lack of awareness, low healthcare expenditures will restrain the market during the corresponding period.
Key Players
Some of the key players in this market are Smith & Nephew (UK), B. Braun Melsungen AG (Germany), Ethicon US, LLC. (US), Erbe Elektromedizin GmbH (Germany), COVIDIEN (US), CONMED Corporation (US), MEDICON (US), Integra LifeSciences Corporation (US), Synergetics USA, Inc. (US), Stryker Corporation (US), KARL STORZ & Co. (US), and KLS Martin (Germany).
Latest Industry News
  • Surgical services at the Georgetown Public Hospital have received a donation of medical equipment and supplies from the government of China. 28 DEC 2018
  • AppOrtho is utilizing the High Country’s first robot-assisted surgery system to aid with knee replacement surgeries. 3 JAN 2019
Posted by at No comments:

Ophthalmic Suspension Industry Overview, Trends and Market Growth Analysis Research Report 2023

Ophthalmic Suspension Market Information: By Type of Content (Antibiotic, Antifungal, Antibacterial, Steroids, Nsaids and others), By Applications (Bacterial Infections, Retinal Disorders, Glaucoma, Allergies, Diabetic Eye Disease), By End Users (Hospitals, Eye Clinics, Pharmacies, and others) - Global Forecast till 2023
Market Scenario
The global ophthalmic suspension market is expected to exhibit a strong 6.8% CAGR over the forecast period from 2017 to 2023, according to the latest research report from Market Research Future (MRFR). The report profiles the leading players in the global ophthalmic suspension market to provide readers with a clear picture of the major drivers and restraints affecting the market growth over the forecast period. The global ophthalmic suspension market is also analyzed with respect to its segmentation in order to pinpoint the leading segments likely to drive the market’s progress over the coming years.
The suspension in the form of used to treat eye infections and related symptoms are generally termed as ophthalmic suspension. Generally it used in a combination of two such as antibiotics and a corticosteroid for more effective treatment. Various bacterial eye infections such as conjunctivitis are treated by ophthalmic suspension.   
Increasing prevalence of eye diseases across the globe is one of the major factors contributing to the growth of this ophthalmic suspension market size. Moreover, increasing geriatric population which are most prone to eye disorders, and growing number of bacterial infections cases in children will also boost the growth of the market. Furthermore, according to WHO (2014), glaucoma is the second major cause of blindness in the world which will increase the market growth.
On the other hand, the side-effects of ophthalmic suspension may hamper the market growth during the corresponding period.
Key Players 
  • Novartis AG (Alcon)
  • ALLERGAN
  • Pfizer Inc.
  • Merck & Co., Inc.
  • Bausch & Lomb Incorporated
  • Falcon Group
  • Valeant
  • Bayer AG
  • Genentech, Inc.   
Segmentation
The global ophthalmic suspension market is segmented on the basis of type of content, which is segmented into antibiotic, antifungal, antibacterial, steroids, NSAIDs (non-steroidal anti-inflammatory drugs) and others.
On the basis of applications, it is segmented into bacterial infections, retinal disorders, glaucoma, allergies, diabetic eye disease, and others. Bacterial infection is further conjunctivitis, scleritis, and others. Retinal disorder is further segmented into macular degeneration, branch retinal vein occlusion, central retinal vein occlusion, congenital x-linked retinoschisis, and others.   
On the basis of end user, the market is segmented into hospitals, eye clinics, pharmacies, and others.
Regional Analysis
The American region accounted for the largest share of the global ophthalmic suspension market due to increasing prevalence of eye related diseases and increasing demand for new ophthalmic suspension for its treatment. Moreover, increasing geriatric population is another major factor responsible for the market growth in American countries.
In Asia Pacific, increasing government support for research & development in healthcare domain, growing number of ophthalmic clinics, and increasing prevalence of eye related diseases drives the growth of the market in this region.
Europe is the second largest ophthalmic suspension market across the globe owing to increasing awareness regarding eye related diseases, growing technological advancements in healthcare domain and increasing investment in healthcare domain by government.
The Middle East & Africa is expected to show a least market share due to less availability of medical facilities, and less development in healthcare domain.
Posted by at No comments:

Molecular Modelling Market Growth Opportunities, Analysis and Forecasts Report 2019-2023

Molecular Modelling Market Research Report: by Product (Software and Services), by Application (Drug Development, Drug Discovery, and Others), by End-user (Pharmaceutical & Biotechnology Companies, Research & Academic Centers) - Global Forecast Till 2023
Market Scenario
Molecular modelling comprises an array of computational techniques used in creation, manipulation, and representation of the various reactions and structures of molecules. Its applications included drug discovery and development but have since extended into computational chemistry and materials science. Rising use of molecular modelling by scientists to run multiple simulations can expedite the drug development process considerably.
The global molecular modelling market share is anticipated to expand at a 15.16% CAGR from 2018 to 2023 (forecast period), according to the latest report by Market Research Future (MRFR). Investments in R&D by pharmaceutical and biotechnology companies and prevalence of chronic diseases are factors certain to spur market growth over the forecast period.
According to the Brookings Private Sector Global Health R&D Project, nearly USD 159.9 Bn has been dispensed for healthcare R&D in developed and developing regions. Out of which, the majority can be credited to pharmaceutical companies. The booming biosimilars and biologics industry is bound to propel the market demand in the coming years. But the high R&D expenditure can impede market growth.
Report Overview
The report covers the latest trends affecting the market to provide the most accurate forecasts and predictions. By correlating the historical data with key market dynamics, our analysts make highly astute projections regarding the scope of the market and its future prospects. MRFR’s report includes a thorough analysis of the global molecular modelling market segmented by product, application, end-user, and region. Trends and opportunities are highlighted coupled with the market share of companies as well as their valuation in the market. It analyzes new revenue sources for players and outlines the various strategies implemented by players.
Segment Overview
Products in the molecular modelling market include software and services. Major applications include drug discovery, drug development, and others. Drug discovery is sub-segmented into direct drug design, indirect drug design, and molecular mimicry. End-users of the market include research centers and academic institutions, pharmaceutical and biotechnology companies, and others.
The segments covered in the report are analyzed with respect to four major regions – Americas, Europe, Asia Pacific (APAC), and the Middle East and Africa (MEA), with respective country-level market sizing. The definition and advantages of “molecular modelling” is outlined in the report for a comprehensive understanding of the market. The report discusses in detail the various players and their respective strategies to enhance their value chain.
Competitive Landscape
Some of the key players in the molecular modelling market include Cresset, Acellera Ltd., Schrödinger, LLC, Optibrium, BioSolve-IT, Simulations Plus, Inc., Chemical Computing Group, Certara, L.P, OpenEye Scientific Software, Dassault Systèmes, Cambridge Crystallographic Data Centre, and others. New product launches and clinical trials are used to gauge the success of drugs. Various strategies such as acquisitions, partnerships, joint ventures, and distribution agreements are used by these players to gain a major share in the market.
The report offers comprehensive profiles on these market players and assesses their current standing in the market. Company history coupled with annual turnover, profit margins, segmental share, SWOT analysis, growth strategies, new product launches, mergers and acquisitions (M&A) activities, and latest R&D initiatives are discussed in granular detail.
Opportunity:
Countries situated near the equator have become the budding ground for many chronic diseases such as chagas, dengue, leprosy, and rabies due to problematic climactic conditions forcing these countries to employ the latest advancements into their system. Governments of developing countries have initiated education programs and projects such as the Janala Project in Bangladesh, ProjectABC in Nigeria, Tostan in Senegal, Yoza in South Africa, and BridgeIT in Tanzania, and others to create awareness regarding the conditions and healthcare IT tools.
Regional Analysis
The Americas dominates the global molecular modelling market owing to well-developed technology, increasing prevalence of the people suffering from cardiovascular diseases, and increasing government support for research & development. Furthermore, high healthcare expenditure and increasing R&D activities have fuelled the growth of the market in this region.
Europe holds the second position in the global molecular modelling market, which is followed by Asia Pacific. It is expected that the government support for research & development and availability of funds for research will drive the market. Asia Pacific is the fastest growing molecular modelling market due to the presence of rapidly growing economy, developing healthcare technology, increasing healthcare expenditure, and huge patient pool.
On the other hand, the Middle East & Africa holds the least share of the market due to limited availability of medical facilities, less availability of funds, and poor political conditions in Africa.
Posted by at No comments:
Subscribe to: Posts (Atom)